Navigation Links
Schering-Plough Reports Financial Results for 2009 First Quarter
Date:4/21/2009

ave been established at both Schering-Plough and Merck, and these teams have been meeting collaboratively in order to plan for a smooth and effective integration. Until the merger closes, both companies will continue to operate independently. The transaction is subject to approval by Schering-Plough and Merck shareholders and the satisfaction of customary closing conditions and regulatory approvals, including expiration or termination of the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, as well as clearance by the European Commission under the EC Merger Regulation and certain other foreign jurisdictions.

Recent Developments

The company also offered the following summary of recent significant developments that have previously been announced, including:

  • Responded to the FDA's complete response letter for SAPHRIS (asenapine) sublingual tablets, which was received in January 2009. SAPHRIS is under review for the acute treatment of schizophrenia in adults and for the acute treatment of manic or mixed episodes associated with bipolar I disorder in adults as monotherapy. (Announced Feb. 20, 2009)
  • Announced a license agreement between Nobilon, Schering-Plough's human vaccine business unit, and the World Health Organization to provide access to pandemic influenza vaccine manufacturing technology to developing countries. (Announced Feb. 23)
  • Launched AFRIN PureSea(TM) Hydrating Nasal Rinse. (Announced March 3)
  • Received European Commission (EC) and FDA approvals for an intravenous formulation of temozolomide, a chemotherapy treatment for certain primary brain tumors, and received EC approval for a sachet packaging presentation for TEMODAL Capsules. (Announced March 5)
  • Received FDA approval for expanded labeling for PEGINTRON and REBETOL combination therapy allowing for ret
    '/>"/>

SOURCE Schering-Plough Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related medicine news :

1. EPA Names Schering-Plough 2009 EPA ENERGY STAR(R) Partner of the Year
2. Settlement Hearing on Schering-Plough Corporation Securities Litigation to be Held on June 1, 2009 at 2:00 P.M.
3. Schering-Plough Withdraws From Barclays Capital Global Healthcare Conference
4. Schering-Plough Declares Quarterly Dividends on Common Shares and Mandatory Convertible Preferred Stock
5. Schering-Plough Completes Enrollment of Boceprevir Registration Studies in Treatment-Naive and Treatment-Experienced HCV Patients
6. Schering-Plough Selects Benefit Advocates for Health Advocacy
7. Schering-Plough Schedules Conference Call and Webcast for 2008 Fourth Quarter and Full Year Earnings
8. Schering-Plough Announces European Submission of Fertility Medicine Corifollitropin Alfa
9. Lupin Announces Litigation Settlement with Schering-Plough Corporation for Desloratadine(R)
10. Schering-Plough Announces FDA Approval of PEGINTRON(TM) and REBETOL(R) Combination Therapy for Treating Pediatric Hepatitis C
11. Schering-Plough to Webcast R&D Update Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... From November 24, 2014, Siddhi Yoga ... 2014 in its Goa retreat . This is the ... winters, from November to March, Siddhi Yoga will organize four ... Goa. The Goa training sessions will conclude in March 2015. ... training, the 10th intake is also a 200 YTT ...
(Date:12/19/2014)... December 19, 2014 Consilium Staffing, ... the AMSUS Society for Federal Health Professionals annual ... tenens industry to military and federal healthcare providers. ... National Veterans Small Business Engagement (NVSBE) conference last ... to be a vital solution in addressing our ...
(Date:12/19/2014)... 18, 2014 (HealthDay News) -- The tragic death from "rat-bite ... carried by the pet rodents, according to a report from ... fever is a rare but potentially fatal illness that should ... and when a history of rodent exposure is reported," said ... Epidemic Intelligence Service. The case outlined in the report ...
(Date:12/19/2014)... analogue eye drops -- a common form of glaucoma ... in patients with the eye disease, a new study ... the Moorfields Eye Hospital and UCL Institute of Ophthalmology ... newly diagnosed with open-angle glaucoma -- the most common ... causes of blindness. About 45 million people worldwide ...
(Date:12/17/2014)... Marlborough, Mass. (PRWEB) December 17, 2014 ... College of Osteopathic Medicine (ACOM), which welcomed its ... Virtual Desktop Infrastructure (VDI) to seamlessly support bring ... learning – and teaching – experience. The solution, ... Citrix NetScaler , Dell server and storage ...
Breaking Medicine News(10 mins):Health News:Siddhi Yoga’s 10th intake of YTT started in Goa on November 24, 2014 2Health News:Siddhi Yoga’s 10th intake of YTT started in Goa on November 24, 2014 3Health News:Consilium Staffing Increasing Awareness of Locum Tenens through Conference Appearances 2Health News:Scratch From Pet Rat Kills Child; CDC Warns of Risk 2Health News:Study Supports Benefit of Widely Used Glaucoma Drug 2Health News:Alabama College of Osteopathic Medicine Deploys Desktop Virtualization Solution from Citrix, Dell and Unidesk 2Health News:Alabama College of Osteopathic Medicine Deploys Desktop Virtualization Solution from Citrix, Dell and Unidesk 3
... comes to mating, male chimpanzees have the opposite taste when ... species, human beings, //according to a study published Tuesday. ... older females and turn up their nose at younger ones. ... on studies of a group of Kanyawara chimpanzees in Uganda's ...
... a mother of two children died of breast cancer due to ... //Dr.John Philip was not qualified to read mammograms according to the ... Jackson. ,The woman who is identified as Mrs. A, ... her that she was normal. When she went for a second ...
... Centre at Canada's University //of British Columbia conducted a ... Alzheimer’s disease. , ,During the study, the researchers ... low-oxygen levels for about 16 hours a day, which ... normal levels of oxygen. ,After a month ...
... that sex does not increase the chances of heart attack, ... to movie mythology. //The study reported that ‘while sex causes ... could lift the likelihood 20-folds’. ,The review by ... analyse triggers for heart attacks, including sexual activity, cocaine use, ...
... US government has awarded three more contracts to buy and ... 2.7 million people, at a cost of $199.45 million. ... (HHS) the contracts are for a total of 5.3 million ... to GlaxoSmithKline (GSK) for 800,000 doses, $40.95 million to Novartis ...
... who suffer from allergy to grass pollen will now ... introduced, tablet based //vaccine named Grazax? is being marketed ... treatment. ,Allergy from grass pollen prominently disrupts quality ... social interaction severely .Statistics reveal that over 45 million ...
Cached Medicine News:Health News:US Orders More H5N1 vaccine 2
(Date:12/19/2014)... Kan. , Dec. 18, 2014   ... ), a biopharmaceutical company focused on the licensing, ... animals, today announced positive results from its pivotal ... drug for treating pain in dogs with osteoarthritis. ... in pain assessment scores that were statistically significant ...
(Date:12/19/2014)... robust development with the growth pace keeping at 20%-30% in ... the size of China separating membrane ... to 16.3%. It is projected that China ... around 20% in the upcoming years and that the figure ... An integrated membrane industrial system has taken shape in ...
(Date:12/17/2014)... , Alemania, December 17, 2014 ... año anterior, con un alto nivel de gasto en ... año fiscal 2013/14 (finalizado el 30 de septiembre de ... ciento a 4.287 millones de euros (año anterior: 4.190 ... la moneda desfavorables. Las ganancias (EBIT) crecieron un 14 ...
Breaking Medicine Technology:Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 2Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 3Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 4Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 5Separation Membranes Market (Company, Country & Application) Research Reports for Global and Chinese Regions 2Separation Membranes Market (Company, Country & Application) Research Reports for Global and Chinese Regions 3ZEISS confirma su posición en un entorno difícil 2
... RX600 is a versatile, fully powered orthopaedic ... built-in traction facilities, a powered centre break ... extremely versatile too. ,<br.,In fact the RX600 ... as it is for traction procedures. The ...
... For complete orthopedic trauma procedures. ... system, the orthopedic trauma table top ... for easy patient positioning and provides ... key trauma procedures: hip pinnings; femur, ...
... The EXOGEN 2000+ device provides a ... nonunion or the acceleration of fresh ... home for 20 minutes daily, or ... your physician determines your fracture to ...
... cannulated interference screws have a ... screw divergence. Screws are available ... lengths. Screws are supplied sterile, ... and 9mm dia. (screws are ...
Medicine Products: